Conformis

Conformis EBIT

Delisted

The EBIT of Conformis (CFMS) as of Oct 23, 2026 is -46.28 M USD. In the previous year, EBIT was 68,000.00 USD — a change of -68,155.88% (lower).

EBIT

-46.28 MUSD

YoY

-68,155.88%

Last updated:

In 2022, Conformis's EBIT was -46.28 M USD, a -68,155.88% increase from the 68,000.00 USD EBIT recorded in the previous year.

The Conformis EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT
Date
EBIT
Jan 1, 2018
-35.42 M USD
Jan 1, 2019
-25.13 M USD
Jan 1, 2020
-25.11 M USD
Jan 1, 2021
68,000.00 USD
Jan 1, 2022
-46.28 M USD
Jan 1, 2023 (e)
-35.89 M USD
Jan 1, 2024 (e)
-30.54 M USD
Jan 1, 2025 (e)
15.21 M USD
The Conformis EBIT history
YEAREBITYoY
est15.21 MUSD-149.82%
est-30.54 MUSD-14.91%
est-35.89 MUSD-22.44%
-46.28 MUSD-68,155.88%
68,000.00USD-100.27%
-25.11 MUSD-0.06%
-25.13 MUSD-29.06%
-35.42 MUSD-36.57%
-55.85 MUSD-0.53%
-56.14 MUSD+0.33%
-55.96 MUSD+23.19%
-45.43 MUSD-3.98%
-47.31 MUSD+7.03%
-44.20 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Conformis Revenue

Conformis Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2018
89.79 M USD
-35.42 M USD
-43.37 M USD
Jan 1, 2019
77.43 M USD
-25.13 M USD
-28.48 M USD
Jan 1, 2020
68.76 M USD
-25.11 M USD
-24.29 M USD
Jan 1, 2021
99.86 M USD
68,000.00 USD
-2.41 M USD
Jan 1, 2022
62.05 M USD
-46.28 M USD
-50.47 M USD
Jan 1, 2023 (e)
53.00 M USD
-35.89 M USD
-36.39 M USD
Jan 1, 2024 (e)
58.94 M USD
-30.54 M USD
-33.43 M USD
Jan 1, 2025 (e)
60.69 M USD
15.21 M USD
2.41 M USD

Conformis Margins

Conformis stock margins

The Conformis margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Conformis. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Conformis.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2018
54.00 %
-39.45 %
-48.30 %
Jan 1, 2019
47.45 %
-32.45 %
-36.78 %
Jan 1, 2020
49.03 %
-36.52 %
-35.33 %
Jan 1, 2021
65.77 %
0.07 %
-2.42 %
Jan 1, 2022
37.41 %
-74.58 %
-81.34 %
Jan 1, 2023 (e)
37.41 %
-67.72 %
-68.65 %
Jan 1, 2024 (e)
37.41 %
-51.82 %
-56.71 %
Jan 1, 2025 (e)
37.41 %
25.07 %
3.97 %

Conformis Stock analysis

What does Conformis do? Conformis Inc is a medical technology company that specializes in the development, manufacturing, and marketing of customized implantable joint prostheses. The company is based in the United States and has its headquarters in Billerica, Massachusetts. History: Conformis Inc was founded in 2004 by Dr. Philipp Lang, an orthopedic surgeon and pioneer in the development of customized implants. The company's goal was to develop an innovative technology that could be used to manufacture individual prostheses for patients. Initially, Conformis focused on the development of custom prostheses for the knee joint. Over the years, the company has expanded its offerings to include other joints such as the hip. Business model: Conformis' business model is based on providing customized, implantable prostheses. Unlike traditional prostheses that are available in standard sizes, Conformis prostheses are individually manufactured for each patient. The company uses advanced 3D printing technology to produce a prosthesis that matches the specific anatomical features of the patient. Conformis prostheses offer numerous advantages over conventional prostheses. By customizing the prosthesis, a better fit and higher stability can be achieved. This can lead to better function and increased lifespan of the prosthesis. Additionally, Conformis prostheses can be implanted faster and more easily than traditional prostheses. Divisions: Conformis offers a variety of products for different joints. Knee prostheses: Conformis offers a wide range of custom knee prostheses. The offerings include partial replacement prostheses that only replace a part of the knee, as well as complete knee prostheses. All prostheses are individually manufactured for each patient to ensure optimal fit and function. Hip prostheses: Conformis also offers custom prostheses for the hip. These prostheses are designed to provide high stability and better fit. The hip prostheses are also individually made for each patient. Shoulder prostheses: Conformis offers custom prostheses for the shoulder, which are also tailored to the patient's anatomy. These prostheses can be used for rotator cuff defects as well as other shoulder problems. Products: The core product of Conformis is custom joint prostheses. The company's prostheses are individually manufactured for each patient to ensure optimal fit and function. Advanced technologies such as 3D printing and digital imaging are used in the production process. Conformis also offers implants for specialized procedures such as medial knee replacement. In addition to the prostheses, Conformis also offers implants such as screws, pins, and plates that can be used to fix bones during surgery. Conclusion: Conformis is a leading company in the medical technology field and offers specialized products that cater to the needs of patients. The company specializes in customized implantable joint prostheses and offers a wide range of products that are tailored to the needs of patients. Conformis has earned an excellent reputation in the industry and continues to strive to develop innovative products that improve the lives of patients. Conformis is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Conformis's EBIT

Conformis's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Conformis's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Conformis's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Conformis’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Conformis stock

EBIT of Conformis is -46.28 M USD in 2022.

EBIT of Conformis changed from 68,000.00 USD to -46.28 M USD, representing a -68,155.88% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Conformis since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's Conformis historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Conformis

All Key Metrics — Conformis